Cart
sales@molnova.com
N-Formyl-Met-Ala-Ser
CAS No. 17351-32-5
N-Formyl-Met-Ala-Ser( —— )
Catalog No. M30371 CAS No. 17351-32-5
N-Formyl-Met-Ala-Ser is a peptide, binds to formyl peptide receptors on neutrophils.N-Formyl-Met-Ala-Ser Peptide (fMet-Ala-Ser) binds to formyl peptide receptors on neutrophils. N-Formylmethionine-containing peptides including the most potent and known member, N-formyl-Met-Leu-Phe (FMLP or fMet-Leu-Phe) stimulate human neutrophils by a receptor-dependent mechanism.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
Biological Information
-
Product NameN-Formyl-Met-Ala-Ser
-
NoteResearch use only, not for human use.
-
Brief DescriptionN-Formyl-Met-Ala-Ser is a peptide, binds to formyl peptide receptors on neutrophils.N-Formyl-Met-Ala-Ser Peptide (fMet-Ala-Ser) binds to formyl peptide receptors on neutrophils. N-Formylmethionine-containing peptides including the most potent and known member, N-formyl-Met-Leu-Phe (FMLP or fMet-Leu-Phe) stimulate human neutrophils by a receptor-dependent mechanism.
-
DescriptionN-Formyl-Met-Ala-Ser is a peptide, binds to formyl peptide receptors on neutrophils.N-Formyl-Met-Ala-Ser Peptide (fMet-Ala-Ser) binds to formyl peptide receptors on neutrophils. N-Formylmethionine-containing peptides including the most potent and known member, N-formyl-Met-Leu-Phe (FMLP or fMet-Leu-Phe) stimulate human neutrophils by a receptor-dependent mechanism.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number17351-32-5
-
Formula Weight335.38
-
Molecular FormulaC12H21N3O6S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (298.17 mM)
-
SMILES——
-
Chemical NameSequence:Foemyl-{Met}{Ala}{Ser}
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
IPSU
IPSU is an antagonist of OX2 receptor. IPSU Exhibits approximately six-fold selectivity for OX2 versus OX1 receptors.
-
AZD0780
AZD0780 (EX-A6975) is an oral small molecule PCSK9 inhibitor being developed by AstraZeneca as a first-in-class treatment for patients with dyslipidemia that is uncontrolled with statins alone.
-
Myristoyl glutamic a...
Myristoyl glutamic acid sodium, a surfactant in amino acid cleansers, has mild antibacterial properties and cleanses the skin surface of excess oil and dirt.
